ArticleOncoimmunology2016

Combined treatment with dabrafenib and trametinib with immune-stimulating antibodies for BRAF mutant melanoma.

Blanca Homet Moreno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.